Dermatol. praxi. 2007;1(3):107-110

Cosmetic advantages of treatment with photodynamic active substances of certain dermatological diseases

MUDr. Milena Jirásková CSc1, Ing. Lubor Jirásek CSc2
1 Dermatovenerologická klinika 1. LF UK a VFN, Praha
2 FEL ČVUT Praha

In about last 20 years there has been a growing effort in making use of photoactive substances that after incorporation in cells are able to use the energy of noninvasive radiation to liquidate diseased cells by programmed death, so called apoptosis. This effort begins to be effective by registration of a new medication containing methylaminolevulinate – a hydrophilic ester of δ-aminolevulinic acid. Other sensibilizers that could broaden the treatment choice and potentially enable a choice according diseased cells, location of involved tissue etc. are being explored.

Keywords: photodynamic treatment, photosenbilizers

Published: January 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jirásková M, Jirásek L. Cosmetic advantages of treatment with photodynamic active substances of certain dermatological diseases. Dermatol. praxi. 2007;1(3):107-110.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bernet A, Solver A, Warbe T. Skin scrape cytology in the dg. of nodular basale cell ca for treatment by PDT. Acta Dermato-Venereolog. 79,1999; 2: 147-149. Go to original source... Go to PubMed...
    2. Bretschko E, Szeimies RM, Landthaler M, Lee G. Topical 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Evaluation of stratum corneum permeability in vitro. Journal of Controlled Release 1996; 42: 203-208. Go to original source...
    3. Calzavara-Pinton P, Szeimies RM, Ortel B. Photodynamic therapy and Fluorescence diagnosis in Dermatology. Elsevier 2001: 372.
    4. Fritsch C, Goerz G, Ruzicka T. Photodynamic Therapy in Dermatology. Arch. Dermatol. 1998; 134: 207-214. Go to original source... Go to PubMed...
    5. Jirásková M, Vosmík F, Lapeš M, Jirsa M, Stádník, B. Experiences with Local Photodynamic Therapy with TPPS4 and Non-coherent Light. Sborník Jahrestagung der Deutchen Geseltschaft für Biomedizinische Technik München 22.-24. 10. 1997.
    6. Jirásková M, Jirásek L, Štork J, Vosmík F, Jirsa M. Fotodynamická diagnostika a terapie v dermatologii. Zkušenosti s aplikací TPPS4 u některých kožních afekcí. Časopis lékařů českých 142, 2003; 8: 493-499.
    7. Kacerovská D, Pizinger K, Resl V, Cetkovská P, Jirsa M, Šmíd F. Srovnání účinnosti dvou fotosenzibilizátorů ve fotodynamické terapii kožních nádorů. Čes.-slov. Derm. 81, 2006; 3: 148-152.
    8. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J. Am. Acad. Derm. 2000; 42: 389-413. Go to original source... Go to PubMed...
    9. Karrer S, Szeimies RM, Abels C, Landthaler M. The Use of Photodynamic Therapy for Skin Cancer. Onkologie 1998; 21: 20-27. Go to original source...
    10. Khan SA, Dougherty TJ, Mang TS. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur. J. Cancer. 1993; 294, 29A: 1986-1990. Go to original source... Go to PubMed...
    11. Krutmann J, Hönigsmann H. (Hrsg.). Hadbuch der dermatologischen Phototherapie und Photodiagnostik. Springer-Verlag Berlin Heudelberg New York 1997: 407. Go to original source...
    12. Kurwa HA, Barlow RJ. The role of PDT in dermatology. Clin.Exp. Dermatol. 1999; 24(3): 143-148. Go to original source... Go to PubMed...
    13. Lapeš M, Petera J, Jirsa M. Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)-porphin (TPPS4). Photochem. Photobiol 1996; 36: 205-207. Go to original source... Go to PubMed...
    14. Morton CA, Whitehurst C, Moseley H, McColl HM, Moore JV, MacKie RM, Path FRCP. Photodynamic therapy for Large or Multiple Patches of Bowen Disease and Basal Cell Carcinoma. Arch Dermatol. 2001; 137: 319-324. Go to PubMed...
    15. Soler et al. PDT by ?-ALA. Acta dermat. Venereol 1999; 79(3): 204-206. Go to original source...
    16. Stables GI. Photodynamic Therapy in dermatology. J.Dermat. Treatment 10, 1999; 3: 213-219. Go to original source...
    17. Szeimies RM, Calzavara-Pinton PG, Karrer LS, Ortel B, Landthaler M. Topical Photodynamic Therapy in Dermatology. Journal of Photochemistry and Photobiology B: Biology 1996; 36: 213-219. Go to original source... Go to PubMed...
    18. Vaicová M, Ettler K. Naše klinické zkušenosti s použitím fotodynamické terapie u pacientů s bazaliomem a morbus Bowen (srovnání účinnosti dvou fotosenzibilizátorů). Čes.-slov. Derm. 2004; 70(6): 200-204.
    19. Vančíková Z. Principles of the Photodynamic Therapy and its Impact on the Immune System. Sborník Lékařský 1998; 99(1): 1-11.
    20. Zima T, Jirásková M, Jirsa M, Jirsa Mjr., Stádník B, Hradová V. Skin localization of Photosenzitization in Rats. Jahrestagung der Deutchen Geseltschaft für Biomedizinische Technik München 22.-24. 10. 1997.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.